Roche

Forecast & Rating8 analysts currently cover Roche, with about 50.0% giving a positive rating — meaning they expect the stock to rise. The average price target is $60.59, about 14.9% upside from the current price of $52.75. Price targets span a fair range, indicating some disagreement among institutions. Historically, about 34.8% of past price targets were eventually met, which adds credibility. For you, this means institutional views on Roche are split — bulls and bears coexist, so you'll need to weigh it against your own judgment. Data as of Sep 10, 2026; for reference only and not investment advice.